TSG Consumer Partners has sold its 30% stake in enhanced bottled water company Glaceau (a.k.a. Energy Brands Inc.) to The Tata Group. The deal is valued at $677 million, including both the TSG stake and additional growth capital. Glaceau is a New York-based company whose brands include of Vitaminwater, Fruitwater and Smartwater. www.glaceau.com
ChemoCentryx Inc., a Mountain View, Calif.-based developer of orally-administered therapeutics that target chemokine and chemoattractant receptor systems, has raised $17.7 million in Series C funding. Backers include Jennison Associates, HBM BioVentures, Orbimed Advisors, Techne Corporation, Alta Partners and GIMV. ChemoCentryx also announced a strategic alliance with GlaxoSmithKline that includes an upfront payment of $63.5 million in cash and equity. The GSK deal also includes research funding and milestone payments that potentially could be worth up to $1.5 billion. www.chemocentryx.com
Vestar Capital Partners of
Octagon Research Solutions Inc., a Wayne, Pa.-based provider of R&D process management solutions for the pharma industry, has raised $10 million in third round funding. Participants include Edison Venture Fund, Phoenix Life Insurance, Ticonderoga Capital and Zurich Financial. www.octagonresearch.com
Kane Reid Securities Group (a.k.a. TradeKing), a Boca Raton, Fla.-based provider of online brokerage services, has raised $6 million in Series B funding, according to a regulatory filing. Battery Ventures led the deal, while existing shareholders include Milestone Merchant Partners and OCA Venture Partners. www.tradeking.com
IPLocks Inc., a San Jose, Calif.